Novartis Investigative Site

Chía, Cundinamarca 250001

0 studies enrolling now · 4 studies all time

What they study most

Autoimmunity, Inflammation, Primary Prevention of Atherosclerotic Cardiovascular Disease, Systemic Lupus Erythematosus

Studies at this site

• Secukinumab Open Label Roll-over Extension Protocol — Recruiting now
• Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). — Recruiting now
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2) — Running, not enrolling